| Attribute |
Value |
| 52 Week Change |
0.04768598 |
| Address1 |
2,200 Pennsylvania Avenue N.W. |
| Address2 |
Suite 800W |
| All Time High |
296.06384 |
| All Time Low |
0.044633 |
| Ask |
194.93 |
| Ask Size |
400 |
| Audit Risk |
7 |
| Average Analyst Rating |
1.4 - Strong Buy |
| Average Daily Volume10 Day |
3,208,380 |
| Average Daily Volume3 Month |
4,182,670 |
| Average Volume |
4,182,670 |
| Average Volume10Days |
3,208,380 |
| Beta |
0.986 |
| Bid |
194.83 |
| Bid Size |
200 |
| Board Risk |
9 |
| Book Value |
74.316 |
| City |
Washington |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Compensation Risk |
5 |
| Country |
United States |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
195.29 |
| Current Ratio |
1.874 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,774,915,200 |
| Day High |
197.02 |
| Day Low |
194.26 |
| Debt To Equity |
37.487 |
| Display Name |
Danaher |
| Dividend Date |
1,776,988,800 |
| Dividend Rate |
1.6 |
| Dividend Yield |
0.83 |
| Earnings Call Timestamp End |
1,776,772,800 |
| Earnings Call Timestamp Start |
1,776,772,800 |
| Earnings Growth |
0.125 |
| Earnings Quarterly Growth |
0.102 |
| Earnings Timestamp |
1,776,774,600 |
| Earnings Timestamp End |
1,776,774,600 |
| Earnings Timestamp Start |
1,776,774,600 |
| Ebitda |
7,834,999,808 |
| Ebitda Margins |
0.31891 |
| Enterprise To Ebitda |
19.415 |
| Enterprise To Revenue |
6.192 |
| Enterprise Value |
152,117,460,992 |
| Eps Current Year |
8.40256 |
| Eps Forward |
9.0986 |
| Eps Trailing Twelve Months |
5.04 |
| Esg Populated |
0 |
| Ex Dividend Date |
1,774,569,600 |
| Exchange |
NYQ |
| Exchange Data Delayed By |
0 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fax |
202 828 0860 |
| Fifty Day Average |
199.882 |
| Fifty Day Average Change |
-4.5920105 |
| Fifty Day Average Change Percent |
-0.022973606 |
| Fifty Two Week Change Percent |
4.768598 |
| Fifty Two Week High |
242.8 |
| Fifty Two Week High Change |
-47.51001 |
| Fifty Two Week High Change Percent |
-0.19567549 |
| Fifty Two Week Low |
180.03 |
| Fifty Two Week Low Change |
15.2599945 |
| Fifty Two Week Low Change Percent |
0.084763624 |
| Fifty Two Week Range |
180.03 - 242.8 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
283,789,800,000 |
| Five Year Avg Dividend Yield |
0.42 |
| Float Shares |
630,089,452 |
| Forward Eps |
9.0986 |
| Forward P E |
21.46374 |
| Free Cashflow |
4,554,874,880 |
| Full Exchange Name |
NYSE |
| Full Time Employees |
58,000 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Governance Epoch Date |
1,775,001,600 |
| Gross Margins |
0.59231997 |
| Gross Profits |
14,552,000,512 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.10785 |
| Held Percent Institutions |
0.84801 |
| Implied Shares Outstanding |
707,699,419 |
| Industry |
Diagnostics & Research |
| Industry Disp |
Diagnostics & Research |
| Industry Key |
diagnostics-research |
| Ir Website |
http://phx.corporate-ir.net/phoenix.zhtml?c=82105&p=irol-irhome |
| Is Earnings Date Estimate |
0 |
| Language |
en-US |
| Last Dividend Date |
1,774,569,600 |
| Last Dividend Value |
0.4 |
| Last Fiscal Year End |
1,767,139,200 |
| Last Split Date |
1,696,204,800 |
| Last Split Factor |
1,128:1000 |
| Long Business Summary |
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was incorporated in 1969 and is headquartered in Washington, the District Of Columbia. |
| Long Name |
Danaher Corporation |
| Market |
us_market |
| Market Cap |
138,206,609,408 |
| Market State |
REGULAR |
| Max Age |
86,400 |
| Message Board Id |
finmb_265621 |
| Most Recent Quarter |
1,767,139,200 |
| Net Income To Common |
3,600,000,000 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
137,137,993,413 |
| Number Of Analyst Opinions |
22 |
| Open |
194.58 |
| Operating Cashflow |
6,416,000,000 |
| Operating Margins |
0.2217 |
| Overall Risk |
7 |
| Payout Ratio |
0.2545 |
| Peg Ratio |
1.2554 |
| Phone |
202 828 0850 |
| Previous Close |
193.78 |
| Price Eps Current Year |
23.241724 |
| Price Hint |
2 |
| Price To Book |
2.6278324 |
| Price To Sales Trailing12 Months |
5.6254725 |
| Profit Margins |
0.1471 |
| Quick Ratio |
1.398 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
strong_buy |
| Recommendation Mean |
1.4 |
| Region |
US |
| Regular Market Change |
1.5099945 |
| Regular Market Change Percent |
0.77923137 |
| Regular Market Day High |
197.02 |
| Regular Market Day Low |
194.26 |
| Regular Market Day Range |
194.26 - 197.02 |
| Regular Market Open |
194.58 |
| Regular Market Previous Close |
193.78 |
| Regular Market Price |
195.29 |
| Regular Market Time |
1,776,450,586 |
| Regular Market Volume |
2,423,301 |
| Return On Assets |
0.04183 |
| Return On Equity |
0.07053 |
| Revenue Growth |
0.046 |
| Revenue Per Share |
34.472 |
| Sand P52 Week Change |
0.36506534 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Share Holder Rights Risk |
2 |
| Shares Outstanding |
707,699,419 |
| Shares Percent Shares Out |
0.0098 |
| Shares Short |
6,939,368 |
| Shares Short Previous Month Date |
1,772,150,400 |
| Shares Short Prior Month |
6,293,889 |
| Short Name |
Danaher Corporation |
| Short Percent Of Float |
0.011 |
| Short Ratio |
1.68 |
| Source Interval |
15 |
| State |
DC |
| Symbol |
DHR |
| Target High Price |
310.0 |
| Target Low Price |
220.0 |
| Target Mean Price |
256.81818 |
| Target Median Price |
262.5 |
| Total Cash |
4,615,000,064 |
| Total Cash Per Share |
6.526 |
| Total Debt |
19,696,001,024 |
| Total Revenue |
24,568,000,512 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
1.28 |
| Trailing Annual Dividend Yield |
0.0066054286 |
| Trailing Eps |
5.04 |
| Trailing P E |
38.748016 |
| Trailing Peg Ratio |
1.2554 |
| Triggerable |
1 |
| Two Hundred Day Average |
209.62245 |
| Two Hundred Day Average Change |
-14.3324585 |
| Two Hundred Day Average Change Percent |
-0.06837273 |
| Type Disp |
Equity |
| Volume |
2,423,301 |
| Website |
https://www.danaher.com |
| Zip |
20,037-1701 |